(+) MK-801 and phencyclidine induced neurotoxicity do not cause enduring behaviours resembling the positive and negative symptoms of schizophrenia in the rat

Basic and Clinical Pharmacology and Toxicology

Volumn 95, Issue 5, 2004, Pages 241-246

  Sams Dodd, Frank ^a,b  

^a H LUNDBECK A S   (Denmark)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; LOCOMOTION; MALE; NEGATIVE SYNDROME; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; POSITIVE SYNDROME; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; STEREOTYPY;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; MALE; MOTOR ACTIVITY; NEUROTOXICITY SYNDROMES; PHENCYCLIDINE; RATS; RATS, WISTAR; SCHIZOPHRENIA; SOCIAL BEHAVIOR; STEREOTYPED BEHAVIOR;

ANIMALIA; ATAXIA; PRIMATES;

EID: 9444260946     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2004.pto950507.x     Document Type: Article

References (31)

1. Bodi, T., I. Share, H. Levy & J. H. Mover: Clinical trials of phencyclidine (sernyl) in patients with psychoneurosis. Antibiotic Med. Clin. Therapy 1959, 6, 79-84.
2. Carlsson, M. & A. Carlsson: Schizophrenia: a subcortical neuro-transmitter imbalance syndrome? Schiz. Bull. 1990, 16, 425-432.
3. Castellani, S. & P. M. Adams: Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur. J. Pharmacol. 1981, 73, 143-154.
4. Corso, T. D., M. A. Sesma, T. I. Tenkova, T. C. Der, D. F. Wozniak, N. B. Farber & J. W. Olney: Multifocal brain damage induced by phencyclidine is augumented by pilocarpine. Brain Res. 1997, 752, 1-14.
5. Davies, B. M. & H. R. Beech: The effects of 1-arylcyclohexylamine (sernyl) on twelve normal volunteers. J. Ment. Sci. 1960, 106, 912-914.
6. De Angelis, G. G. & E. Goldstein: Treatment of adolscent phencyclidine (PCP) abusers. Amer. J. Drug Alcohol Abuse 1978, 5, 399-414.
7. Ellison, G. & R. C. Switzer III: Dissimilar patterns of degeneration in brain following four different addictive stimulants. Neuroreport 1993, 5, 17-20.
8. Ellison, G.: Competetive and non-competetive NMDA-antagonists induce similar limbic degeneration. Neuroreport 1994, 5, 2688-2692.
9. Erard, R., P Luisada & R. Peele: The PCP psicosis: rolonged intoxication or drug-precipitated funcional iones? J. Psychoactive Drug 1980, 12, 235-251.
10. Farber, N. B., M. T. Price, J. Labruyere, J. Nmenich, H. St. Peter, D. F. Wozniak & J. W. Olney: Antipsychotic Drugs Block Phencyclidine Receptor-Mediated Neurotoxicity. Biol. Psychiatr. 1993, 34, 119-121.
11. Farber, N. B., D F. Wozniak, M. T. Price, J. Labruyere, J. Huss, H. St. Peter & J. W Olney: Age-specfic neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenic? Biol. Psychiatr. 1995, 38, 788-796.
12. Farber, N. B., J. Foster, N. L. Duhan & J. W. Olney: Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity. Schiz. Res. 1996, 21, 33-37.
13. Fauman, M. A. & B. J. Fauman: Chronic phencyclidine (PCP) abuse: a psychiatric prospectus. J. Clin. Psychiatr. 1980, 42, 307-315.
14. File, S. E.: The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Meth. 1980, 2, 219-238.
15. Fix, A. S., J. W Horn, K. A. Weghtman, C. A. Johnson, G. G. Long, R. W. Storts, N. B. Farber, D. F. Wozniak & J. W. Olney: Neuronal vacuolization and necrosis induced by the noncompetetive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): A light and electron nicroscopic evaluation of the rat retrosplenial cortex. Exp. Neurol. 1993, 123, 204-215.
16. Horváth, Z. C., J. Czopf & G. Buzsáki: MK-801-inducedneuronal damage in rats. Brain Res. 1997, 753, 181-195.
17. Huitema, B. E.: The analysis of covariants and alternatives. Wiley & Sons, New York 1980.
18. Jackson, D. M., C. Johansson, L. M. Lindgren & A. Bengtson: Dopamine receptor anatagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacol. Biochem. Behav. 1994, 41, 465-471.
19. Jentsch, J. D., A. Tran, D. Le, K. D. Youngren & R. H. Roth: Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacol. 1997a, 17, 92-9.
20. Jentsch, J. D., D. E. Redmond Jr., J. D Elsworth, J. R. Taylor, K. D. Youngren & R. H. Roth: Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 1997b, 277, 953-955.
21. Krystal, J. H., L. P. Karper, J. P. Seibyl, G. K. Freeman, R. Delaney, J. D. Bremner, G. R. Heninger, M. B. Browers & D. S. Charney: Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatr. 1994, 51, 199-214.
22. Olney, J. W., J. Labruyere & M. T. Price: Pathological changes induced by cerebrocortical neurons by phencyclidine and related drugs. Science 1989, 244, 1360-1362.
23. Olney, J. W., J. Labruyere, G. Wang, D. F. Wozniak, M. T. Price & M. A. Sesma: NMDA Antagonist neurotoxicity: Mechanism and prevention. Science 1991, 254, 1515-1518.
24. Olney, J. W. & N. B. Farber: Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatr. 1995, 52, 998-1007.
25. Sams-Dodd, F: Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats. Behav. Pharmacol. 1995a, 6, 55-65.
26. Sams-Dodd, F: Automation of the social interaction test by a video tracking system: Behavioural effects of repeated phencyclidine treatment. J. Neurosci. Meth. 1995b, 59, 157-168.
27. Sams-Dodd, F: Phencyclidine-induced stereotyped behaviour and social isolation in the rat: A possible animal model of schizophrenia. Behav. Pharmacol. 1996, 7, 3-23
28. Sams-Dodd, F: Effect of novel antipsychotic drugs on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test. Behav. Pharmacol. 1997, 8, 196-215.
29. Sams-Dodd, F: Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Rev. Neurosci. 1999, 10, 59-90.
30. Siegel, R. K.: Phencyclidine and ketamine intoxication a study of 4 populations of recreational users. In: National institute of drug abuse research monograph #21. Eds.: R. C. Peterson & R. C. Stillman. NIH Press, Washington DC, 1978, pp 119-147.
31. Wrigth, H. H., E. A. Cole, S. R. Batey & K. Hanna: Phencyclidine-induced psychosis: Eight-year follow-up of ten cases. South Med. J.l 1988, 81, 565-567.